PT
Pamela Thompson
Also known as: Pamela Cunliffe
Self Employed, University of Manchester, University of Oxford, Lancaster University
Employment
-
University of Manchester Honorary Research Fellow2015 - 2016
-
University of Manchester Research Fellow2014 - 2015
-
Self Employed Science Editor2010 - Present
-
University of Manchester Research Associate2007 - 2014
-
University of Manchester Research Associate2001 - 2007
-
University of Manchester Research Associate1999 - 2000
Education
-
University of Oxford DPhil (Molecular Genetic Analysis of Mottled Mice)1995 - 1999
-
Lancaster University BSc(Hons) Biological Science1992 - 1995
Projects & Funding
Projects & funding information is unavailable.
Publications (22)
- Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome Save
- Heritable variation at the chromosome 21 gene ERG is associated with acute lymphoblastic leukemia risk in children with and without Down syndrome Save
- Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia. Save
- A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1. Save
- The 9p21.3 risk of childhood acute lymphoblastic leukaemia is explained by a rare high-impact variant in CDKN2A. Save
- Differences in meiotic recombination rates in childhood acute lymphoblastic leukemia at an MHC class II hotspot close to disease associated haplotypes. Save
- Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype. Save
- Genetic variation in the extended major histocompatibility complex and susceptibility to childhood acute lymphoblastic leukemia: a review of the evidence. Save
- SNP association mapping across the extended major histocompatibility complex and risk of B-cell precursor acute lymphoblastic leukemia in children. Save
- HLA-DPβ1 Asp84-Lys69 antigen-binding signature predicts event-free survival in childhood B-cell precursor acute lymphoblastic leukaemia: results from the MRC UKALL XI childhood ALL trial. Save